35 reports

From that price standpoint, the efficacy delivery wasn' t enough.

  • Biosimilar
  • United States
  • AbbVie Inc.
  • Pfizer Inc.
  • Remicade group

" If there is the possibility of continuous delivery of the drug, this could be according to me, a means for having more prescription in respect to teriparatide. "

  • Biosimilar
  • East Asia
  • United States
  • Amgen Inc.
  • Eli Lilly & Co.

In the same month, Abbott initiated a Class ## recall of ##, ## units of the Certitude Delivery System due to a molding overflow defect.

  • Biosimilar
  • United States
  • Market Size
  • Medtronic, Inc.
  • Zimmer Biomet Holdings, Inc.

In January 2015, UNILIFE entered into a definitive global strategic agreement with the company for the customization and delivery of its injectable drug delivery systems to use with AbbVie' s drug portfolio, which is indicated for the treatment of autoimmune c

  • Biosimilar
  • United States
  • AbbVie Inc.
  • Amgen Inc.
  • Johnson & Johnson

MESALAMINE IS ONE OF THE MOST EXTENSIVELY USED DRUG AMONGST ALL ##-ASA AGENTS.

  • Biosimilar
  • Italy
  • United States
  • Pfizer Inc.
  • Remicade group

KOLs favored either the non-steroid drugs or the novel drug delivery methods.

  • Biosimilar
  • United States
  • Clearside Biomedical, Inc.
  • pSivida Corp.
  • Santen Pharmaceutical Co., Ltd.

DRUG DELIVERY IMPLANTS FOR GEOGRAPHIC ATROPHY.

  • Biosimilar
  • United States
  • Allergan plc
  • Novartis AG
  • Ophthotech Corporation

Sustol utilizes Heron' s Biochronomer polymer-based drug delivery technology (Heron therapeutics, press release, August ##, 2016).

  • Biosimilar
  • United States
  • Amgen Inc.
  • BeyondSpring Pharmaceuticals Inc.
  • Helsinn Group
  • MACULAR EDEMA - PIPELINE BY LUPIN LTD, H1 2018

It also offers drug delivery mechanisms for treating diseases of the eye.

  • Biosimilar
  • Pharmaceutical
  • Therapy
  • United States
  • EyeGate Pharmaceuticals, Inc.

In November 2014, Benitec and ##D Molecular Therapeutics entered into a collaboration and licensing agreement to discover and develop optimized AAV vectors for delivery of proprietary Benitec technology to treat ophthalmic disease indications. ##DMT will deploy its proprietary AAV vector disc

  • Biosimilar
  • Ophthalmology
  • United States
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.
  • POST MENOPAUSAL OSTEOPOROSIS - PIPELINE BY ENTERIS BIOPHARMA INC, H2 2019

Enteris' drug delivery solution offers the oral delivery of compounds such as BCS II, III, and IV compounds.

  • Biosimilar
  • Chronic Disease
  • Musculoskeletal Disorder
  • United States
  • Amgen Inc.

MedinCell provides peptides and proteins delivery services.

  • Biosimilar
  • Pharmaceutical
  • United States
  • Deals & Alliance
  • Sandoz Inc.

White, will participate in a panel discussion on retinal drug delivery.

  • Biosimilar
  • Therapy
  • United States
  • Product Initiative
  • Clearside Biomedical, Inc.

The company employs its drug delivery systems to advance drug compounds and drug delivery methods.

  • Biosimilar
  • United States
  • Company
  • Corporate Finance
  • Pfizer Inc.

They have overcome many of the drug delivery issues previously seen in RNA products, and we believe Mirna has the potential to become one of the leading miRNA companies.

  • Biosimilar
  • Therapy
  • United States
  • Corporate Finance
  • Pfizer Inc.
  • RETINAL VEIN OCCLUSION - PIPELINE BY EYEGATE PHARMACEUTICALS INC, H1 2018

It also offers drug delivery mechanisms for treating diseases of the eye.

  • Biosimilar
  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • United States

Enteris' drug delivery solution offers the oral delivery of compounds such as BCS II, III, and IV compounds.

  • Biosimilar
  • Genitourinary System Disease
  • United States
  • Company
  • Product Initiative

drug delivery devices with one deal during the period 2012 to YTD 2018.

  • Biosimilar
  • Pharmaceutical
  • United States
  • Deals & Alliance
  • Alteogen Inc

A microvolume delivery of RTH## may permit sustained delivery and/ or simultaneous treatment with multiple drugs, while maintaining the standard injection volume of ## l.

  • Biosimilar
  • United States
  • Eli Lilly & Co.
  • ImClone Systems Incorporated
  • Ophthotech Corporation

Report delivery with high quality market insights, competitive landscape, etc., as per the proposed contents.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • United States
  • Market Size

It also offers drug delivery mechanisms for treating diseases of the eye.

  • Biosimilar
  • Medical Biotechnology
  • United States
  • Product Initiative
  • Clearside Biomedical, Inc.

Factors such as cost, drug delivery method, and dosing frequency are clearly identified by gastroenterologists as being far less important than symptomatic improvement and promoting mucosal healing.

  • Biosimilar
  • United States
  • Johnson & Johnson
  • Takeda Pharmaceutical Company Limited
  • TiGenix NV

AbbVie discovers and develops novel medicines based on protein-based and targeted drug delivery technologies.

  • Biosimilar
  • Medical Biotechnology
  • Monoclonal Antibody
  • United States
  • Product Initiative

AbbVie discovers and develops novel medicines based on protein-based and targeted drug delivery technologies.

  • Biosimilar
  • Pharmaceutical
  • United States
  • Company
  • Momenta

It concentrates on the development and drug delivery companies, drug discovery, and medical technology companies through its TVM capital life science division.

  • Biosimilar
  • Medical Biotechnology
  • Pharmaceutical
  • United States
  • Biogen Idec Inc.

Grunenthal focuses on discovering new methods to treat pain and developing new platform technologies for drug delivery.

  • Autoimmune Disease
  • Biosimilar
  • Monoclonal Antibody
  • Therapy
  • United States
  • NEUTROPENIA - PIPELINE BY USV PVT LTD, H1 2018

The center undertakes research and development of biosimilars, peptides, chemical processes and drug delivery.

  • Biosimilar
  • Medical Biotechnology
  • Monoclonal Antibody
  • United States
  • Product Initiative

The company develops active pharmaceutical ingredients, formulations and drug delivery technologies for the treatment of cancer and inflammatory diseases.

  • Autoimmune Disease
  • Biosimilar
  • Therapy
  • United States
  • Product Initiative

Enteris' drug delivery solution offers the oral delivery of compounds such as BCS II, III, and IV compounds.

  • Biosimilar
  • Genitourinary System Disease
  • United States
  • Product Initiative
  • Bayer AG

Its vault technology platform is a biocompatible, non-immunogenic and non-toxic delivery platform that accelerates human drug applications unlike viruses and other synthetic drug delivery technologies.

  • Biosimilar
  • Research And Development
  • Vaccine
  • United States
  • Novavax, Inc.